Pharma Marketing Network

MAY 15, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. One of the biggest challenges is ensuring that patient privacy is protected.

Pharmaceutical 59

Pharmaceutical Marketing Electronics Media 59

Curzon Consulting

NOVEMBER 10, 2022

Consultant Contact me. +44 Amber-Valetta is a consultant with 2 years’ experience in consulting split between design and management consulting.; Having worked extensively on cutting-edge technologies Amber-Valetta has expertise in data analysis, continuous improvement activities and health and safety.

Consulting 52

Consulting Engineering Safety Management 52

Impetus Digital

MARCH 20, 2023

So is it possible for remote working to really be successful in such a heavily regulated field as pharmaceuticals? Pros of remote working in the pharmaceutical industry Remote working involves allowing employees to carry out their duties from home, away from the regular office environment. We take a look.

Pharmaceutical 52

Pharmaceutical Consulting Management Training 52

Pharma Marketing Network

MARCH 23, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. One of the biggest challenges is ensuring that patient privacy is protected.

Pharmaceutical 52

Pharmaceutical Marketing Electronics Media 52

Pharma Marketing Network

APRIL 1, 2023

Pharma-Mkting.com is a leading resource for professionals in the pharmaceutical and medical device industries. One of the key areas of expertise for Pharma-Mkting.com is pharmaceutical marketing. Overall, Pharma-Mkting.com is a leading resource for professionals in the pharmaceutical, medical device, and digital health industries.

Pharma 52

Pharma Medical Pharmaceutical Marketing 52

European Pharmaceutical Review

MARCH 5, 2024

The four analytica forums offer practical best-practice lectures, with the Occupational Safety and Security Forum highlighting dangers in daily laboratory work through impressive live demonstrations. Pharmaceutical analytics is considered a cross-cutting technology that ensures product quality and economic success.

Consulting 83

Consulting Pharmaceutical Transportation Safety 83

European Pharmaceutical Review

MARCH 5, 2024

Ensuring safety and efficacy of medical devices UK perspective Medical Devices/IVDs Regulatory Quality and Clinical Consultant, Shweta Agarwal, remarked on LinkedIn about a recent MedTech Regulatory Reform webinar by the MHRA.

Medical 78

Medical Manufacturing Food and Drug Administration Safety 78

European Pharmaceutical Review

NOVEMBER 2, 2023

The FDA said its approval of Wezlana is based on “a comprehensive review of scientific evidence demonstrating it is highly similar to Stelara and that there are no clinically meaningful differences between the two products in terms of safety, purity and potency.” Like Stelara, the most serious known side effect of Wezlana is infection.

Food and Drug Administration 84

Food and Drug Administration FDA Side effects Safety 84

pharmaphorum

JULY 21, 2022

The pharmaceutical industry has long been highly regulated to help ensure quality and safety across all aspects of its business. The reinstatement of on-site FDA inspections offers businesses an opportunity to take a fresh look at their sites to help ensure they are complying with quality and safety standards. She has a Ph.D.

FDA 76

FDA Consulting Safety Manufacturing 76

European Pharmaceutical Review

FEBRUARY 8, 2024

Vertex Pharmaceuticals’ once-daily small molecule vanzacaftor/tezacaftor/deutivacaftor (vanza triple) for cystic fibrosis (CF) has gleaned positive results in Phase III trials. A third Phase III study was also part of the programme. Treatment with the vanza triple was well tolerated in all three studies.

Food and Drug Administration 85

Food and Drug Administration Medicine Medical Consulting 85

European Pharmaceutical Review

OCTOBER 20, 2022

“For the first time, we are now able to prescribe a combined hormonal contraceptive tablet containing synthetic E4, plus the well-known progestogen DRSP,” explained Dr Diana Mansour, Consultant in Community Gynaecology and Reproductive Health Care, Newcastle upon Tyne.

Safety 78

Safety Consulting Medicine Healthcare 78

European Pharmaceutical Review

OCTOBER 12, 2023

The new Notification Scheme is based on that outlined in the MHRA’s clinical trials consultation, which was endorsed by 74 percent of those who responded. This will be the case if the trial sponsor can demonstrate the trial meets the MHRA’s criteria, such as safety issues of the investigational medicine.

Ethics 89

Ethics Safety Medicine Consulting 89

European Pharmaceutical Review

OCTOBER 31, 2023

The study, conducted at 99 sites across 12 countries tested the efficacy and safety of a weekly basal injection of icodec (a long-lasting type of insulin) and compared it to a daily basal injection of insulin degludec in adults with type 1 diabetes.

Management 95

Management Consulting Safety Pharmaceutical 95

European Pharmaceutical Review

JANUARY 27, 2023

The new framework will ensure there are no regulatory barriers to innovative manufacturing and that products made via such routes have the same assurances of safety, quality, and effectiveness as those for conventional medicinal products. Clear regulatory expectations and allowing easier product development.

Manufacturing 83

Manufacturing Medicine Consulting Engineering 83

European Pharmaceutical Review

JULY 25, 2022

The European Commission (EC) has issued a draft proposal for a new EU Regulation on blood, tissues and cells (BTC) to help increase the safety and quality of substances of human origin (SoHO). The EC noted that the EDQM’s standards “will now become the primary means to meet the EU standards of quality and safety for BTC.”.

Safety 102

Safety Consulting Healthcare Healthcare 102

Star OUTiCO

MARCH 7, 2022

Recently, there’s been an almost unprecedented demand for reliable pharmaceutical recruitment agencies. In these trying times, the services of a pharmaceutical recruitment agency can significantly help healthcare companies who want to recover from staffing deficiencies. Specialises in the Pharmaceutical Sector. Contact us today.

Recruitment 52

Recruitment Pharmaceutical Healthcare Healthcare 52

European Pharmaceutical Review

NOVEMBER 22, 2023

The safety profile for rucaparib observed in the clinical trial was consistent with current US and European labels for rucaparib. European Patients with this disease “need and deserve new treatment options to improve outcomes, according to Dr Rebecca Kristeleit, Consultant Medical Oncologist and Adjunct Reader, Guy’s and St.

Consulting 79

Consulting Patients Networking Safety 79

European Pharmaceutical Review

MARCH 17, 2023

The clinical trial evaluated the safety and efficacy of efgartigimod in 167 patients. The post First FcRn blocker approved in UK for myasthenia gravis appeared first on European Pharmaceutical Review.

Medicine 88

Medicine Safety Consulting Patients 88

European Pharmaceutical Review

DECEMBER 13, 2022

The following year, the US Congress passed the 1938 Federal Food, Drug and Cosmetic (FD&C) Act, which mandated safety assessments prior to the release of any new drug. The USP also introduced a general monograph for the good distribution practices (GDP) for bulk pharmaceutical excipients (<1197>).

Food and Drug Administration 89

Food and Drug Administration Manufacturing Safety Food 89

European Pharmaceutical Review

AUGUST 28, 2023

Potential of inclisiran for lowering LDL-C These findings “reconfirm and extend prior observations about the safety profile and efficacy of inclisiran for people with ASCVD and those at risk of cardiovascular disease, in whom cholesterol levels are not adequately controlled,” Dr Ray explained.

Food and Drug Administration 95

Food and Drug Administration Consulting Patients Food 95

European Pharmaceutical Review

MAY 18, 2023

A regulatory first Historically, “there have been no licensed treatment options available for NHS patients [with chronic hepatitis D] in England and Wales,” stated Dr Ahmed Elsharkawy, Consultant Transplant Hepatologist and Honorary Senior Clinical Lecturer at the University of Birmingham.

Medicine 81

Medicine Consulting Safety Medical 81

European Pharmaceutical Review

FEBRUARY 2, 2023

Treating Crohn’s disease “There have been limited new treatment options approved for Crohn’s disease in recent years and many people struggle to stay in remission, demonstrating a clear unmet need,” shared Professor James Lindsay, Consultant Gastroenterologist at the Royal London Hospital Barts Health NHS Trust.

Safety 65

Safety Medicine Consulting Patients 65

Pharmaceutical Technology

SEPTEMBER 13, 2022

This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes. An international team of scientific, regulatory, and safety and compliance (GxP) specialists, PharmaLex is based in Germany.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

Clarivate

OCTOBER 19, 2023

Drug candidates have a high rate of failure, as only 10% of de-novo drugs put through clinical trials finally obtain market approval, with the highest rate of attrition occurring at phase I and II of clinical trials (assessing safety, tolerability, dosage, efficacy, and side effects). For example, in the U.S.,

Networking 59

Networking Consulting Safety Side effects 59

European Pharmaceutical Review

MARCH 24, 2023

Regulatory science refers to the scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products. This is according to stakeholder consultation process that took place with EMA’s scientific committees, stakeholders and EU regulatory partners.

Medicine 71

Medicine Consulting Networking Safety 71

European Pharmaceutical Review

MARCH 4, 2024

1 However, the entry of biologics into the pharmaceutical market is not without unique challenges, particularly when compared to small molecule drugs. Advancement of these oral medical devices is still in its infancy and further investigation is needed to ensure their effectiveness and safety in use for humans. Pharmaceutics.

Food and Drug Administration 85

Food and Drug Administration Transportation FDA Medical 85

European Pharmaceutical Review

NOVEMBER 7, 2022

Overall safety data of the trial was consistent with prior data. The post Empagliflozin reduces risk of chronic kidney disease progression appeared first on European Pharmaceutical Review. Statistical risk of kidney disease progression or cardiovascular death observed in the study: HR of 0.72 and 95 percent (CI), 0.64

Transportation 75

Transportation Consulting Safety Medicine 75

pharmaphorum

OCTOBER 12, 2022

Steve Hoare, Quality, Regulatory Science & Safety Policy Director, The Association of the British Pharmaceutical Industry (ABPI). Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals. Sean McPike, Senior Consultant, Global HSE, Eli Lilly.

Engineering 52

Engineering Safety Consulting Medical 52

European Pharmaceutical Review

MARCH 13, 2023

The trial will randomise patients with IIH to determine the efficacy and safety of Presendin versus placebo. Run by Invex Therapeutics, it will randomise 240 adult patients with newly diagnosed IIH with papilloedema to determine the efficacy and safety of Presendin, administered once weekly over 24 weeks.

Safety 80

Safety Patients Consulting Leads 80

European Pharmaceutical Review

MAY 18, 2023

said Dr Alexandra Kent, Consultant Gastroenterologist at King’s College Hospital NHS Trust. Results from the U-EXCEED, U-EXCEL and U-ENDURE “were generally consistent with the known safety profile of upadacitinib in other licensed indications,” AbbVie explained.

Consulting 77

Consulting Marketing Safety Patients 77

pharmaphorum

JULY 28, 2022

The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. The two primary exporters of Active Pharmaceutical Ingredients (APIs), China and India, continue to be affected by periodic lockdowns.

Pharma 88

Pharma FDA Consulting Manufacturing 88

European Pharmaceutical Review

JANUARY 10, 2023

The new Packaging Services zone will unite contract manufacturing organisations (CMO), contract development and manufacturing organisation ( CDMO) and contract packaging and services companies with cutting edge innovations spanning filling, consulting and even approaches to improve environmental impacts.

Manufacturing 69

Manufacturing Consulting Safety Management 69

Pharmaceutical Technology

SEPTEMBER 20, 2022

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Newly emerging technologies have helped in improving the effectiveness and safety of non-sterile commercial dose products.

Leads 52

Leads Marketing Retail Distribution 52

European Pharmaceutical Review

JANUARY 19, 2023

Professor Graham Jackson, Consultant Haematologist at Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust commented: “This treatment has become an important standard of care in relapsed or refractory multiple myeloma over the past five years, so I am delighted with this final decision from NICE.”

Consulting 70

Consulting Safety Patients Pharmaceutical 70

European Pharmaceutical Review

FEBRUARY 22, 2023

6 FDA has also been critical on selection of appropriate dosing levels to balance efficacy and safety considerations with Phosphoinositide 3-kinase (P13K) inhibitors, as resistance could reduce efficacy resulting in long-term safety concerns. He is currently a CMC consultant with an interest in impurities and safety‑based limits.

Food and Drug Administration 73

Food and Drug Administration FDA Safety Food 73

European Pharmaceutical Review

AUGUST 5, 2022

Clinigen Healthcare is recalling three batches of Mexiletine hydrochloride hard capsules, indicated for the treatment of documented arrhythmias, due to a potential risk of under- or overdose, which could have consequences for the safety of patients. Active Pharmaceutical Ingredients: mexiletine hydrochloride. Batch number. Expiry date.

Distribution 84

Distribution Healthcare Healthcare Medicine 84

Pharma Marketing Network

JULY 27, 2022

In the first two weeks after a cancer diagnosis, there are likely dozens of doctor’s visits, tests, consultations, and decision points. The IMPORTANCE of PHARMACOVIGILANCE Safety Monitoring of Medicinal Products. 1 The marketer’s goal is to design easy-to-follow patient guidelines while conforming to med-legal language. Sunny White.

Patients 130

Patients Education Retail Pharma 130